Why the study?
Do admission HbA1c levels predict short-term outcomes in STEMI patients undergoing primary PCI?
Population
608 patients with ST-elevation myocardial infarction who underwent primary percutaneous coronary intervention
Comparison
Admission hemoglobin A1c levels, stratified into… vs Comparison among the three HbA1c strata
Design
Cohort
Follow-up
7 and 30 days
Authors
Loading...
Admission HbA1c should not guide short-term risk assessment after STEMI PCI; leaves open its prognostic value in larger or longer-term cohorts.
Do admission HbA1c levels predict short-term outcomes in STEMI patients undergoing primary PCI?
Admission HbA1c levels are not an independent prognostic marker for short-term outcomes in STEMI patients treated with primary PCI.
Li et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: